Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Consolidated revenues — United States by Year
Consolidated revenues — United States ($M) ($M)
Gilead Sciences Consolidated revenues — United States: $20,876M in FY2025, up 1.4% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-Q / 10-K Disaggregated Revenue & Geographic Information.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consolidated revenues — United States ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20,876 | +1.4% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 20,591 | +5.9% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 19,438 | +2.9% | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 18,884 | -2.0% | Form 10-K (filed 2025-02-28) ↗ |
| FY2021 | Dec 31, 2021 | 19,267 | +5.8% | Form 10-K (filed 2024-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 18,217 | +9.4% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 16,645 | +2.3% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 16,269 | -10.6% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 18,194 | -6.0% | Form 10-K (filed 2019-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 19,354 | -8.9% | Form 10-K (filed 2019-02-26) ↗ |
| FY2015 | Dec 31, 2015 | 21,234 | +16.8% | Form 10-K (filed 2018-02-27) ↗ |
| FY2014 | Dec 31, 2014 | 18,182 | – | Form 10-K (filed 2017-02-27) ↗ |
Breakdown
What makes up consolidated revenues — United States
Cite this data
StockData. (2026). Gilead Sciences Consolidated revenues — United States ($M), annual FY2014–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/geo-rev-us
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.